Healius Limited Stock price

Equities

HLS

AU0000033359

Healthcare Facilities & Services

Market Closed - Australian S.E. 12:10:52 2024-02-22 am EST 5-day change 1st Jan Change
1.375 AUD +4.17% Intraday chart for Healius Limited -3.85% -15.90%
Sales 2024 * 1.73B 1.13B Sales 2025 * 1.82B 1.19B Capitalization 822M 539M
Net income 2024 * 5M 3.28M Net income 2025 * 36M 23.6M EV / Sales 2024 * 1.3 x
Net Debt 2024 * 1.43B 934M Net Debt 2025 * 1.34B 881M EV / Sales 2025 * 1.19 x
P/E ratio 2024 *
138 x
P/E ratio 2025 *
28.2 x
Employees 10,500
Yield 2024 *
-
Yield 2025 *
1.99%
Free-Float 87.37%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Healius Limited

1 day+4.17%
1 week-3.85%
Current month-0.72%
1 month+3.77%
3 months-25.07%
6 months-51.75%
Current year-15.90%
More quotes
1 week
1.21
Extreme 1.21
1.49
1 month
1.21
Extreme 1.21
1.49
Current year
1.21
Extreme 1.21
1.70
1 year
1.18
Extreme 1.182
3.31
3 years
1.18
Extreme 1.182
5.54
5 years
1.18
Extreme 1.182
5.54
10 years
1.18
Extreme 1.182
5.54
More quotes
Managers TitleAgeSince
Chief Executive Officer - 15-06-30
Director of Finance/CFO - 23-02-28
Chief Tech/Sci/R&D Officer - 21-03-31
Members of the board TitleAgeSince
Director/Board Member 67 15-08-02
Chairman 65 21-02-24
Director/Board Member - 22-03-30
More insiders
Date Price Change Volume
24-02-22 1.375 +4.17% 1 499 471
24-02-21 1.32 -5.71% 8,062,888
24-02-20 1.4 -1.06% 1,696,791
24-02-19 1.415 -1.74% 1,080,006
24-02-16 1.44 -0.35% 1,718,682

Delayed Quote Australian S.E., February 22, 2024 at 12:10 am EST

More quotes
Healius Limited is an Australia-based healthcare company. The Company operates through two segments: Pathology, and Imaging. The Pathology segment is a provider of pathology services, including specialty pathology and clinical trials. The Imaging segment is a provider of imaging and scanning services at standalone imaging sites, hospitals, and medical centers. The Company has a network of pathology laboratories, collection centers, and diagnostic imaging centers. It provides specialty diagnostic services to consumers and their referring practitioners. The Company's brands include Laverty Pathology, QML Pathology, Dorevitch Pathology, Western Diagnostic Pathology, Genomic Diagnostics, Abbott Pathology, IQ Pathology, Vetnostics, TML Vetnostics, Agilex Biolabs, Lumus Imaging, and others. The Company provides healthcare services that are accessible and efficient while supporting the coordination and continuity of quality patient care.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
1.375 AUD
Average target price
1.31 AUD
Spread / Average Target
-4.73%
Consensus
  1. Stock
  2. Equities
  3. Stock Healius Limited - Australian S.E.
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer